FDA Globalization Act Earns Support for Inspections, Concern Over Details

Drug Industry Daily
While more overseas inspections of drugmaking facilities and more funds for them secured industry and bipartisan political support at yesterday’s hearing on a draft bill to enhance the FDA’s authority, a number of the draft’s provisions drew criticism.

To View This Article:


Subscribe To Drug Industry Daily